Exogenous c-Myc Blocks Differentiation and Improves Expansion of Human Erythroblasts In vitro

BACKGROUND: Engineered blood has the greatest potential to combat a predicted future shortfall in the blood supply for transfusion treatment. The production of red blood cells from hematopoietic stem cells in the laboratory is possible but the mass production of red blood cells to the level present...

Descripción completa

Detalles Bibliográficos
Autores principales: Geiler, Cristopher, Andrade, Inez, Greenwald, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249898/
https://www.ncbi.nlm.nih.gov/pubmed/25473453
http://dx.doi.org/10.15283/ijsc.2014.7.2.153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249898/
https://www.ncbi.nlm.nih.gov/pubmed/25473453
http://dx.doi.org/10.15283/ijsc.2014.7.2.153

Ejemplares similares